Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Nobuhiko, Koga"'
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Aira Uchida, Yoko Sagara, Yuko Nakano, Hidekazu Tamai, Masayuki Tojikubo, Yuji Hiromatsu, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 4, Pp 738-740 (2022)
Abstract Interleukin‐6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti‐interleukin‐6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, is considered a candidate for immune
Externí odkaz:
https://doaj.org/article/6f3791905db6491caaa8af6a29ed0a8a
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Aira Uchida, Yoko Sagara, Hidekazu Tamai, Yuko Nakano, Masayuki Tojikubo, Yuji Hiromatsu, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1507-1510 (2020)
Abstract This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 pati
Externí odkaz:
https://doaj.org/article/cda2fb21e4d24c82a6dcb44c219f78bb
Autor:
Eiji Kawasaki, Takahiro Fukuyama, Erisa Kuriyama, Aira Uchida, Yoko Sagara, Hidekazu Tamai, Yuko Nakano, Masayuki Tojikubo, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Abstract Statins are widely used medications for the treatment of hypercholesterolemia, as well as prevention of cardiovascular disease. We report two patients with type 1 diabetes who developed autoimmune hepatitis after the administration of statin
Externí odkaz:
https://doaj.org/article/a806a79d04f84e3bb5b75447e0283c8b
Autor:
Eiji Kawasaki, Akira Okada, Aira Uchida, Takahiro Fukuyama, Yoko Sagara, Yuko Nakano, Hidekazu Tamai, Masayuki Tojikubo, Nobuhiko Koga
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 990-996 (2019)
Abstract Aim/Introduction Autoantibodies to the 65 kDa isoform of glutamic acid decarboxylase (GADA) are a valuable diagnostic and predictive marker for type 1 diabetes. Recently, it has been reported that a significant proportion of sera in the comm
Externí odkaz:
https://doaj.org/article/5167460efa6947759d500f612f5be49d
Autor:
Yoshiya Orita, Kyoko Umeji, Toshiya Soejima, Tomohiro Kawasaki, Kimihiro Kajiyama, Hisashi Koga, Ryota Fukuoka, Keisuke Hirai, Kazuki Haraguchi, Yurie Fukami, Taichi Okonogi, Hiroshige Yamabe, Nobuhiko Koga
Publikováno v:
The American Journal of Cardiology. 159:36-43
Fraction flow reserve (FFR) derived from computed tomography (FFRCT) has been proposed to be an effective gatekeeper for invasive angiographic referral. The purpose of the present study is to examine the real-world diagnostic performance of FFRCT and
Autor:
Yuji Hiromatsu, Hidekazu Tamai, Nobuhiko Koga, Eiji Kawasaki, Yoko Sagara, Aira Uchida, Yuko Nakano, Masayuki Tojikubo, Takahiro Fukuyama
Publikováno v:
Journal of Diabetes Investigation. 13:738-740
Interleukin-6 is a pleiotropic cytokine that plays a pathogenic role in type 1 diabetes. Therefore, anti-interleukin-6 receptor antibody, tocilizumab, used for the treatment of rheumatoid arthritis, is considered a candidate for immune intervention i
Autor:
Nobuhiko Koga, Aira Uchida, Masayuki Tojikubo, Yuko Nakano, Yoko Sagara, Hidekazu Tamai, Eiji Kawasaki, Erisa Kuriyama, Takahiro Fukuyama
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1673-1676 (2020)
Statins are widely used medications for the treatment of hypercholesterolemia, as well as prevention of cardiovascular disease. We report two patients with type 1 diabetes who developed autoimmune hepatitis after the administration of statin. The fir
Publikováno v:
Journal of medical ultrasonics (2001). 49(4)
Autor:
Mariko Harada-Shiba, Shun Ishibashi, Nobuhiko Koga, Shizuya Yamashita, Shinichi Oikawa, Hiroyuki Daida, Daisaku Masuda, Ryo Naito, Hideaki Bujo, Hidenori Arai
Publikováno v:
Journal of atherosclerosis and thrombosis. 29(8)
Aims Lipoprotein(a) [Lp(a)] is a plasma lipoprotein consisting of a low-density lipoprotein (LDL)-like particle with apolipoprotein (Apo)(a), attached via a disulfide bond to Apo B100. Previous studies have shown that high Lp(a) levels are associated
Publikováno v:
Diabetol Int
AIMS: Relationship between baseline eGFR and the rate of decline in eGFR was investigated in diabetic kidney disease. MATERIALS AND METHODS: Patients with type 2 diabetes with microalbuminuria (MI) (n = 124) or macroalbuminuria (MA) (n = 81) received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9ded4a83b15c48902ed0f7fb737bbc
https://europepmc.org/articles/PMC8733097/
https://europepmc.org/articles/PMC8733097/